Scientific Conferences & Speaking Engagements

SCIENTIFIC CONFERENCES 

• Twelfth Annual Conference on Vaccine Research
  Annual Vaccine Meeting National Foundation Infectious Diseases 
  Baltimore, Maryland, USA
  April 27-29, 2009
  
  
• Fifth Annual Conference on Protein Therapeutics 
  Cambridge HealthTech Institute, San Diego, CA, USA
  January 12 - 16, 2009
  
  
• Elsevier Vaccine Second Global Congress
  Boston, MA, USA
  December 7-9, 2008


• U.S. Civilian Research and Defense Foundation
  Brucellosis as a Trans-boundary Infection of Animals and Humans which needs to be Managed by Cooperative Efforts of Different Countries: an International Workshop
  Serpukhov district, Moscow region, Russia
  June 2-4, 2008
  
  
• Eleventh Annual Conference on Vaccine Research
  Annual Vaccine Meeting National Foundation Infectious Diseases 
  Baltimore, Maryland, USA
  May 5-7, 2008
  
  
• Elsevier Vaccine: 25 Years of Publication 
  Amsterdam, The Netherlands 
  December 7-9, 2007

SPEAKING ENGAGEMENTS

• November 2011: Dr. Peter Nara, Keynote Address. International Conference and Exhibition on Vaccines and Vaccination. Nov. 22-24. Philadelphia, Penn.
  
  
• November 2011: Dr. Peter Nara, Chemical and Biological Defense Science and Technology (CBD S&T) Conference. Inner Armor for the Solider and Homeland Security, Las Vegas, Nevada.
  
  
• November 2010    Dr. Peter Nara,  Key note: The 21st century of medicine: One medicine, one health, one science. Modern Veterinary Vaccines & Adjuvants MVVA 2010 17-19 November 2010 Sofitel Budapest Chain Bridge, Budapest, Hungary.
  
  
• October 2010: Dr. Peter Nara, 4th Vaccine  and Annual ISV Congress, New Insights from In vitro and human infections with Human Rhinovirus, Vienna, Austria.
  
  
• August 2010: Dr. Peter Nara, Keynote invited lecture- “Perspectives on advancing preventative medicine through vaccinology at the comparative     veterinary, human and conservation medicine interface: not missing the opportunities” American Chemical Society and The Industrial Bio-based Technology Subdivision of ACS Fall 2010 National Meeting & Exposition----ACS IBT Boston Fall Symposium 2010,  Boston, Massachusetts, USA.
  
  
• November 2009: Dr. Peter Nara, Invited Keynote Lecture " Deceptive Imprinting: The Next Major Decade in Systems Immunobiology."  Donahue Auditorium, Gordon Science Center, ASA Gray Biological Society, Utica College , New York.
  
  
• July 2009: Dr. Peter Nara, Invited Keynote lecturer Des Monies University School of Osteopathic Medicine Summer Scholar Research Symposium- “The End of the Jennerarian and Therapeutic era in medicine? New insights: from Deceptive Imprinting to creating new partnerships in prevention sciences”, Des Moines, Iowa.
  
  
• June 2009: Invited Plenary Lecturer at The 8th Elsinore Meeting on Infection Immunity Statens Serum Institut, Copenhagen, Denmark.
  
  
• May 2009: Dr. Peter Nara, Key note Lecture 3rd Annual ISU Vaccines, Immunity and Wellbeing Symposium : The End of the Jennerian and Therapeutic Era in medicine? New Insights: from Deceptive Imprinting to Creating New Partnerships in Prevention Sciences for Sustainable Healthcare, Ames, Iowa.
  
  
• April 2009: Dr. Peter Nara, Invited Lecturer National Shang hai Veterinary research institute-Center for Agriculture and Animal Science, Shang hai, China.
  
  
• April 2009: Dr. Peter Nara, Key note lecture 3rd Annual Vaccines Summit Asia –“Deceptive Imprinting and vaccine design”, Singapore, Singapore.
  
  
• Feb. 2009: Dr. Peter Nara, Plenary Lecture International Conference on Current Trends in Biotechnology and implications in Agriculture, Sardar Vallabh Bhai Patel University of Agriculture and Technology, Modipuram, Meerut India.
  
  
• Feb. 2009: Lecturer University of Calcutta, Scholl of Biotechnology: Future of Biotechnology in the vaccine arena. Calcutta, India.
   
• January 2009: Dr. Peter L. Nara, President and CEO, "The Antigenic Wall and a New Technology for Deriving New Therapeutic Monoclonal Antibodies", Plenary Address, Fifth Annual Conference on Protein Therapeutics, San Diego, CA, USA.
  January 12-16, 2009.
  
  
• October 2008: Dr. Peter L. Nara, President and CEO, Seminar: "Deceptive Imprinting of Class II Pathogens: Consequences and Countermeasures" Translational Immunovirology and Biodefense Group Mayo Clinic College of Medicine, Rochester, MN, Oct. 13, 2008
  
  
• October 2008: Dr. Peter L. Nara, President and CEO, Speaker: “Improving on Mother Nature’s Immunogenicity” Session Chair: "Vaccines, Reviews, and Future Perspectives- Part II." Ehrlich II, 2nd World Congress on Magic Bullets; A Celebration of the 100th Anniversary of the awarding of the Nobel Prize to Paul Ehrlich; Nurnberg, Germany, Oct.3-5, 2008
  
  
• September 2008: Dr. Peter L. Nara, President and CEO, Seminar: “Deceptive Imprinting and Immune refocusing Technology” Iowa State University Area Proteomics Group Meeting Iowa State University, Sept. 26, 2008
  
  
• September 2008: Dr. Peter L. Nara, President and CEO, Speaker: “New Approaches to Vaccines and Diagnostic's for Animal Health” Iowa Biotechnology Association Meeting, Iowa State University, IA Sept. 17, 2008
  
  
• May 2008: Dr. Gregory J. Tobin, Vice President and COO, Speaker, Eleventh Annual Conference on Vaccine Research (NFID)
  
  
• May 2008: Dr. Peter L. Nara, President and CEO, Symposium Speaker, Conference Co-chair/founder, Eleventh Annual Conference on Vaccine Research (NFID)
  
  
• April 2008: Dr. Peter L. Nara, President and CEO, Seminar: “Deceptive Imprinting of the Host Immune System: What it means for Vaccine Development” Emory Vaccine Conference Center, Emory University, April 28, 2008
  
  
• Mar 2008: Biological Mimetics, Inc. selected as a finalist for Small Business of the Year award, Tech Council of Frederick County, MD.
  
  
• Feb. 2008 Dr. Peter L. Nara, President and CEO, Named to the Congressional Economic Commission, State of Maryland
  
  
• Dec. 2007: Dr. Peter L. Nara, President and CEO, Plenary Speaker- 25th anniversary Vaccine Congress, Amsterdam, The Netherlands, Dec. 9-11, 2007.